News

Morgan Stanley Adjusts Ratings for Key Software Players

Morgan Stanley Adjusts Ratings for Key Software Players

Overview of Morgan Stanley's Software Ratings

Morgan Stanley analysts have recently revised their ratings and price targets for several prominent software companies, identifying both substantial opportunities and potential risks associated with GenAI technologies. In this landscape, Atlassian Corp Plc (NASDAQ: TEAM) has emerged as a standout pick for 2025. The brokerage's assessment reflects a strategic analysis of the market dynamics influencing software firms.

Atlassian's Strong Position

Atlassian's rating has been elevated to 'overweight,' with the price target increased significantly from $259 to $315. This adjustment is rooted in the analysts' recognition of the company's potential for sustained growth and operational efficiency. With forecasts indicating a 20% top-line growth, strong free cash flow, and exciting opportunities in broader market applications and product portfolios, Atlassian continues to impress despite its recent 35% stock price surge. This optimism regarding Atlassian aligns with the firm's ability to navigate the complexities of the market.

Market Opportunities and Challenges

The analysts noted that larger consolidators in the software industry are best positioned to capitalize on emerging opportunities while managing risks effectively. This perspective underscores the dynamic nature of the tech landscape, where competition and technological advancements shape the trajectory of growth.

Datadog and Confluent's Downgrades

In contrast to the optimistic outlook for Atlassian, Datadog (NASDAQ: DDOG) has seen its rating downgraded to 'equal-weight.' This decision stems from a careful balancing act between long-term growth prospects in observability and cloud security and the need to address pressing short-term risks. With shares hovering close to the price target of $143, concerns regarding the company's revenue guidance for 2025 and potential spending slowdowns among AI-native customers have tempered analyst expectations.

Awaited Catalysts

Market watchers are keenly awaiting catalysts that could reinvigorate Datadog's upward momentum, such as increased software spending and advancements in AI-driven product cycles. It's imperative for Datadog to leverage these potential drivers to mitigate the short-term hurdles it currently faces.

Confluent's Performance and Outlook

Similarly, Confluent has faced a downgrade to 'equal-weight' despite a generally positive outlook in the data streaming market. Analysts raised concerns about the company's ability to drive the adoption of Flink, a critical component for data processing. Additionally, they expressed cautiousness regarding 2025 revenue growth projections. Although the price target was slightly adjusted from $30 to $33, this reflects a tempered short-term outlook while maintaining a belief in the long-term opportunities within the data streaming sector.

DigitalOcean's Strategic Upgrade

On a more positive note, DigitalOcean has been upgraded to 'overweight,' now boasting a price target of $41. This strategic upgrade is attributed to the company's shift in focus towards larger customer segments, coupled with favorable valuation metrics. DigitalOcean's adaptability in a competitive landscape has made it a noteworthy player in the software sector.

Prospects for OneStream

OneStream has also received an upgraded rating to 'overweight.' Analysts have pinpointed growth tailwinds attributed to the ERP supercycle and advancements in AI-driven products. This positions OneStream favorably for the potential future upward revisions and reflects confidence in its strategic direction.

Frequently Asked Questions

What are Morgan Stanley's recent activities concerning software companies?

Morgan Stanley adjusted ratings and price targets for major software firms, identifying both opportunities and challenges.

Why was Atlassian Corp Plc rated as a top pick?

Analysts see Atlassian's strong growth potential and operational efficiency as key factors in its top pick status for 2025.

What challenges did Datadog and Confluent face?

Both companies faced downgrades due to near-term challenges, including revenue guidance concerns and adoption issues.

Why was DigitalOcean upgraded?

DigitalOcean's upgrade was driven by its strategic shift toward larger clients and favorable valuation metrics.

What does the future hold for OneStream?

OneStream is positioned for potential upward revisions thanks to growth opportunities in ERP and AI-related products.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PROCEPT Faces Legal Storm Over Sales Practices Missteps

Updated Category News Views 1

Investors Take Aim: A Legal Showdown on the Horizon There's a brewing storm over at PROCEPT BioRobotics—ticker NASDAQ:PRCT if you're tracking. These folks are knee-deep in a securities class action lawsuit from investors who’ve taken a financial wallop. The lawsuits are triggered by allegations of shady sales techniques that artificially bumped up their unit sales...

Continue Reading
Carestream's Enhanced DRX-LC: Imaging Game Changer

Updated Category News Views 1

Rethinking Long-Length Imaging with Carestream The medical imaging sector just got a shot in the arm with Carestream Healthcare International's latest leap in technology. The DRX?LC Detector is not just a fancy update — it's a full-on revolution for long?length imaging. Forget the old days of piecing multiple exposures together, because this innovation simplifies...

Continue Reading
TECNO POVA 8 Pro 5G: Blending Speed with Style

Updated Category News Views 0

TECNO's Newest Launch: A Marriage of Luxurious Design and Performance This ain't just any phone—they've hitched a race car to your pocket. The TECNO POVA 8 Pro 5G Tonino Lamborghini Limited Edition makes a splash, promising to redefine what folks expect from a luxury-tier device, thanks to its endorsed partnership with the iconic Italian brand. But what's all this mean...

Continue Reading
Regeneron: Investors Face Class Action Over Study Flaws

Updated Category News Views 2

Regeneron Investors Grit Teeth Amid Lawsuit Drama The gloves are off in the pharmaceutical battleground, folks. Investors who thought they were riding the big wave with Regeneron Pharmaceuticals (NASDAQ: REGN) are now staring down the barrel of a class action lawsuit. It seems the company’s been caught in a storm of legal action following allegations of misleading...

Continue Reading
TCL's Energy Vision Unveiled at IFA 2026

Updated Category News Views 0

TCL's Forward-Thinking Approach at IFA 2026 IFA 2026 in Berlin got a jolt when TCL Industries and TCL Technology rolled out their ambitious plans under the banner "Inspiration Habitat." By blending cutting-edge smart devices with clean energy advancements, TCL is frantically waving red flags for anyone with an eye on future living trends. The Heartbeat of Inspiration...

Continue Reading
APX Bridges Crypto & Traditional Finance With New Credit Line

Updated Category News Views 0

The Future of Financial Bridging Now here's a scenario that might perk your ears up if you've ever toyed with digital assets: APX Lending is stepping up its game, bringing a regulated five-year revolving line of credit backed by Bitcoin and Ethereum to the world stage. It's like blending your grandma's tried-and-true savings approach with the whiz-bang allure of crypto. A...

Continue Reading
Yardi Virtuoso AI to Shine at CAIC 2026 Toronto

Updated Category News Views 3

The Scene in Toronto: Yardi's Big AI Showcase There's no denying it—Artificial Intelligence has muscled its way into practically every corner of the business world, and now it's making waves in real estate. Yardi, a familiar name in real estate tech circles, is gearing up to flaunt its Yardi Virtuoso Enterprise at the Canadian Apartment Investment Conference (CAIC) in...

Continue Reading
DeFi Technologies Gains More Time for Nasdaq Compliance

Updated Category News Views 1

DeFi Must Step Up To Meet Compliance Challenge Alright, folks, here's the scoop: DeFi Technologies just picked up another 180 days from Nasdaq to get its act together and hit that crucial one-buck minimum bid price. It's like getting extra time on a pop quiz you forgot to study for—useful, but no guarantee they'll pass. What Led to the Extra Time? These guys over at...

Continue Reading
Pentair Faces Class Action Over Fraud Allegations

Updated Category News Views 2

Catastrophe Strikes Pentair Ah, the sweet sound of a lawsuit hammering down on Wall Street—a routine part of corporate life for some of the biggest players in the game. This time, the bell tolls for Pentair plc, and it ain't pretty, folks. News just dropped that investors in New York Stock Exchange: PNR are staring down a newly expanded securities fraud class action...

Continue Reading
ECRI Welcomes Safety Expert Meshkati to Its Board

Updated Category News Views 1

The Safety Maverick Steps into Healthcare They've gone and done it—appointed a rockstar of systems safety to ECRI's Board of Trustees. Professor Najmedin Meshkati, who's practically been around every major industrial accident of the past few decades, is about to shake things up. Imagine the guy who's dissected calamities like the BP Texas City Refinery explosion and the...

Continue Reading

Top 5 Most Recently Viewed Articles

Ascend Wellness Shares Financial Growth Highlights for 2024

Updated Category News Views 160

Ascend Wellness Holdings Financial Highlights AWH experienced significant growth with a reported net revenue of $562 million in the fiscal year, reflecting an 8% year-on-year increase. This growth highlights the company’s resilience and strategic direction in the evolving cannabis landscape. Positive Operational Metrics With adjustments made to enhance efficiency, AWH...

Continue Reading
New 5K Unity Run to Strengthen Community Bonds in Memphis

Updated Category News Views 230

Innovative Partnership Announced in Memphis The National Civil Rights Museum and Unite Memphis have joined forces to promote a powerful message rooted in healing, honor, and hope within the vibrant city of Memphis. This partnership marks a pivotal moment for Unite Memphis, which has impressively grown by 43% in participation last year as it enters its fourth anniversary....

Continue Reading
Ohio Removes CRNA Supervision for Better Care Access

Updated Category News Views 10

Ohio Paves New Paths in Anesthesia Care With a flick of the pen, Ohio made a significant change in its healthcare landscape, opting out of physician supervision requirements for Certified Registered Nurse Anesthetists (CRNAs). Governor Mike DeWine's decision marks Ohio as the 27th state to liberate CRNAs from an outdated mandate. This isn’t your typical shuffle of the...

Continue Reading
Infosys Partners with Google Cloud to Revolutionize AI Solutions

Updated Category News Views 384

Infosys and Google Cloud Collaboration Overview Infosys (NYSE: INFY), renowned for its next-generation digital services, has announced a groundbreaking collaboration with Google Cloud, creating a center of excellence dedicated to enterprise AI innovation. This initiative will leverage cutting-edge technologies, particularly Infosys Topaz, to develop transformative...

Continue Reading
Nucleome Therapeutics: A Shift in Scientific Leadership

Updated Category News Views 152

Nucleome Therapeutics just dropped a bombshell with the appointment of Dr. Michelle Morrow as their Chief Scientific Officer. This move could be a game changer, considering her hefty background in immunology and drug development. Dr. Morrow isn't just a fresh face; she's packing twenty years of experience under her belt, primarily shaping drug discovery strategies at...

Continue Reading